Streetbeat News

Stock Prices

MLTX

MoonLake Immunotherapeutics' stock is trading higher following the announcement of positive 24-week data from the ARGO trial in psoriatic arthritis, along with other research and development updates.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:50 am

EQT

ETRN

Equitrans Midstream (ETRN) shares surged following the announcement of a definitive merger agreement with EQT, where EQT will acquire ETRN in an all-stock transaction valued at $12.50 per share.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:50 am

AUR

DAVA

LPSN

SMSI

SNOW

The article highlights the top 5 oversold tech stocks in March, based on their RSI values being near or below 30, indicating potential undervaluation. These include Smith Micro Software (SMSI), Aurora Innovation (AUR), Snowflake (SNOW), Endava (DAVA), and LivePerson (LPSN), each with recent financial results and stock performance updates.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 11:50 am

SONN

Sonnet BioTherapeutics' shares surged following the clearance to proceed to Phase 2 for its SON-080 clinical trial after an independent DSMB review.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:47 am

FTRE

Fortrea Holdings reported disappointing Q4 financial results, leading to a decline in its share price. The company also announced plans to divest assets related to its Enabling Services segment.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:47 am

AVGO

Baird analyst Tristan Gerra has maintained an Outperform rating on Broadcom (NASDAQ:AVGO) and increased the price target from $1265 to $1500, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:43 am

OSG

Overseas Shipholding Gr (OSG) reported a significant increase in Q4 EPS to $0.26, up from $0.11 YoY, despite a slight decrease in sales to $116.02M from $121.76M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:39 am

NLSP

NLS Pharmaceutics has received approval from the Nasdaq Listing Qualifications Department for its compliance plan submitted on February 23, 2024. This approval is a crucial step for the company in maintaining its listing on the Nasdaq stock market.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:38 am

ELTK

Eltek (NASDAQ:ELTK) reported Q4 earnings of $0.22 per share, missing the consensus estimate of $0.31 by 29.03%, but showed a 57.14% increase from last year. Sales were $12.32M, slightly above the $12.20M estimate, marking a 17.58% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:33 am

EQT

EQT Corp's stock is trading lower following the announcement of a definitive merger agreement to acquire Equitrans Midstream, indicating a significant move in the energy sector.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 11:33 am